PharVision Advisers’s Vistra VST Stock Holding History

PharVision Advisers’s Portfolio VST Stock Details VST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,202	Closed	-$441K	–	528
2024 Q4	$441K	Buy	+3,202	New	+$445K	0.37%	62

Other funds holding VST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PharVision Advisers's VST Position: Q1 2025 in Review

PharVision Advisers sold out of Vistra (VST) in Q1 2025, closing a stake of 3,202 shares — an estimated $441K sold.

PharVision Advisers first reported a position in VST in Q4 2024 and held it in 1 quarter. The position peaked at $441K in Q4 2024. 1,115 funds tracked by Wall St. Rank hold VST as of Q1 2025.

PharVision Advisers reported no remaining Vistra position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 3,202 Vistra shares in Q1 2025, an estimated $441K.
PharVision Advisers first reported a position in Vistra in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Vistra position peaked at $441K in Q4 2024.
1,115 funds tracked by Wall St. Rank held Vistra as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.